Susquehanna International Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $110M | Buy |
665,300
+149,900
| +29% | +$24.6M | 0.01% | 769 |
|
|
2025
Q4 | $82.1M | Buy |
515,400
+55,000
| +12% | +$7.55M | 0.01% | 1013 |
|
|
2025
Q3 | $43.1M | Sell |
460,400
-306,100
| -40% | -$21.6M | ﹤0.01% | 1459 |
|
|
2025
Q2 | $43.6M | Buy |
766,500
+395,700
| +107% | +$21M | 0.01% | 1258 |
|
|
2025
Q1 | $22.6M | Buy |
370,800
+6,400
| +2% | +$545K | ﹤0.01% | 1639 |
|
|
2024
Q4 | $32.8M | Sell |
364,400
-8,900
| -2% | -$1.05M | ﹤0.01% | 1446 |
|
|
2024
Q3 | $48.1M | Buy |
373,300
+28,000
| +8% | +$3.65M | 0.01% | 1116 |
|
|
2024
Q2 | $39.2M | Sell |
345,300
-158,100
| -31% | -$16.9M | 0.01% | 1150 |
|
|
2024
Q1 | $66.8M | Sell |
503,400
-823,300
| -62% | -$107M | 0.01% | 859 |
|
|
2023
Q4 | $162M | Buy |
1,326,700
+1,282,205
| +2,882% | +$98.1M | 0.03% | 484 |
|
|
2023
Q3 | $3.39M | Sell |
44,495
-15,295
| -26% | -$1.57M | ﹤0.01% | 4173 |
|
|
2023
Q2 | $7.08M | Buy |
59,790
+5,835
| +11% | +$727K | ﹤0.01% | 2989 |
|
|
2023
Q1 | $5.32M | Sell |
53,955
-181,275
| -77% | -$24.6M | ﹤0.01% | 3383 |
|
|
2022
Q4 | $33.3M | Buy |
235,230
+50,550
| +27% | +$7.05M | 0.01% | 1132 |
|
|
2022
Q3 | $25.9M | Sell |
184,680
-20,990
| -10% | -$3.85M | 0.01% | 1208 |
|
|
2022
Q2 | $27.7M | Buy |
205,670
+68,845
| +50% | +$11.7M | 0.01% | 1205 |
|
|
2022
Q1 | $42.9M | Buy |
136,825
+92,035
| +205% | +$34.7M | 0.01% | 1087 |
|
|
2021
Q4 | $32.2M | Buy |
44,790
+7,435
| +20% | +$7.12M | ﹤0.01% | 1417 |
|
|
2021
Q3 | $41.3M | Buy |
37,355
+5,260
| +16% | +$6.46M | 0.01% | 1305 |
|
|
2021
Q2 | $47.3M | Buy |
32,095
+2,305
| +8% | +$3.2M | 0.01% | 1233 |
|
|
2021
Q1 | $47M | Buy |
29,790
+9,925
| +50% | +$23.2M | 0.01% | 1147 |
|
|
2020
Q4 | $39.9M | Sell |
19,865
-14,010
| -41% | -$22.3M | 0.01% | 1154 |
|
|
2020
Q3 | $36.3M | Buy |
33,875
+3,985
| +13% | +$4.57M | 0.01% | 1048 |
|
|
2020
Q2 | $35.5M | Buy |
29,890
+15,725
| +111% | +$13.6M | 0.01% | 1013 |
|
|
2020
Q1 | $6.39M | Sell |
14,165
-11,920
| -46% | -$10.8M | ﹤0.01% | 2271 |
|
|
2019
Q4 | $30M | Buy |
26,085
+15,640
| +150% | +$14M | 0.01% | 1119 |
|
|
2019
Q3 | $6.46M | Sell |
10,445
-2,315
| -18% | -$1.92M | ﹤0.01% | 2417 |
|
|
2019
Q2 | $12.8M | Buy |
12,760
+6,825
| +115% | +$6.61M | ﹤0.01% | 1655 |
|
|
2019
Q1 | $7.11M | Sell |
5,935
-4,310
| -42% | -$4.48M | ﹤0.01% | 2073 |
|
|
2018
Q4 | $6.73M | Buy |
10,245
+6,680
| +187% | +$7M | ﹤0.01% | 1962 |
|
|
2018
Q3 | $6.63M | Sell |
3,565
-5,325
| -60% | -$10.5M | ﹤0.01% | 2348 |
|
|
2018
Q2 | $16.9M | Buy |
8,890
+2,525
| +40% | +$4.45M | 0.01% | 1435 |
|
|
2018
Q1 | $10.1M | Sell |
6,365
-4,485
| -41% | -$8.35M | ﹤0.01% | 1755 |
|
|
2017
Q4 | $16.9M | Buy |
10,850
+1,150
| +12% | +$1.76M | 0.01% | 1384 |
|
|
2017
Q3 | $16.6M | Buy |
9,700
+2,445
| +34% | +$3.39M | 0.01% | 1363 |
|
|
2017
Q2 | $9.15M | Buy |
7,255
+4,270
| +143% | +$4.31M | ﹤0.01% | 1770 |
|
|
2017
Q1 | $2.85M | Sell |
2,985
-7,710
| -72% | -$6.87M | ﹤0.01% | 3113 |
|
|
2016
Q4 | $6.7M | Sell |
10,695
-12,060
| -53% | -$9.06M | ﹤0.01% | 2012 |
|
|
2016
Q3 | $22.2M | Buy |
22,755
+20,590
| +951% | +$17M | 0.01% | 939 |
|
|
2016
Q2 | $1.22M | Buy |
2,165
+650
| +43% | +$407K | ﹤0.01% | 4453 |
|
|
2016
Q1 | $831K | Buy |
1,515
+1,290
| +573% | +$816K | ﹤0.01% | 5462 |
|
|
2015
Q4 | $381K | Buy |
+225
| New | +$364K | ﹤0.01% | 7272 |
|
Other funds holding LABU
JF
TRCT
XT
HF
MIG
TSS
AF
Susquehanna International Group's LABU Position: Q1 2026 in Review
Susquehanna International Group increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 24% in Q1 2026, buying an estimated $2.12M and bringing the position to 67,050 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2955.
Susquehanna International Group first reported a position in LABU in Q2 2015 and has held it in 31 quarters since. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.
- Susquehanna International Group held 67,050 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $11.1M as of Q1 2026.
- Susquehanna International Group bought 12,910 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $2.12M.
- Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2955 holding.
- Susquehanna International Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2015 and has held it in 31 quarters since.
- 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.